Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

USA - NYSE:CXT - US2244411052 - Common Stock

62.45 USD
+1.1 (+1.79%)
Last: 11/7/2025, 8:04:00 PM
62.45 USD
0 (0%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CXT. CXT was compared to 123 industry peers in the Electronic Equipment, Instruments & Components industry. CXT has an excellent profitability rating, but there are concerns on its financial health. CXT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CXT was profitable.
CXT had a positive operating cash flow in the past year.
CXT had positive earnings in each of the past 5 years.
In the past 5 years CXT always reported a positive cash flow from operatings.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

CXT's Return On Assets of 5.19% is fine compared to the rest of the industry. CXT outperforms 73.39% of its industry peers.
CXT has a Return On Equity of 12.88%. This is amongst the best in the industry. CXT outperforms 80.65% of its industry peers.
CXT has a Return On Invested Capital of 8.52%. This is in the better half of the industry: CXT outperforms 77.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CXT is above the industry average of 9.51%.
The last Return On Invested Capital (8.52%) for CXT is well below the 3 year average (13.27%), which needs to be investigated, but indicates that CXT had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.19%
ROE 12.88%
ROIC 8.52%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 9.84%, CXT belongs to the best of the industry, outperforming 80.65% of the companies in the same industry.
In the last couple of years the Profit Margin of CXT has declined.
Looking at the Operating Margin, with a value of 17.79%, CXT belongs to the top of the industry, outperforming 92.74% of the companies in the same industry.
CXT's Operating Margin has been stable in the last couple of years.
CXT has a Gross Margin of 42.98%. This is in the better half of the industry: CXT outperforms 74.19% of its industry peers.
In the last couple of years the Gross Margin of CXT has remained more or less at the same level.
Industry RankSector Rank
OM 17.79%
PM (TTM) 9.84%
GM 42.98%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
Compared to 1 year ago, CXT has more shares outstanding
CXT has a worse debt/assets ratio than last year.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.26 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CXT has a Altman-Z score of 2.26. This is in the lower half of the industry: CXT underperforms 64.52% of its industry peers.
CXT has a debt to FCF ratio of 7.66. This is a slightly negative value and a sign of low solvency as CXT would need 7.66 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.66, CXT is in line with its industry, outperforming 54.84% of the companies in the same industry.
A Debt/Equity ratio of 0.96 indicates that CXT is somewhat dependend on debt financing.
The Debt to Equity ratio of CXT (0.96) is worse than 88.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 7.66
Altman-Z 2.26
ROIC/WACC0.93
WACC9.15%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.20 indicates that CXT should not have too much problems paying its short term obligations.
The Current ratio of CXT (1.20) is worse than 84.68% of its industry peers.
CXT has a Quick Ratio of 1.20. This is a bad value and indicates that CXT is not financially healthy enough and could expect problems in meeting its short term obligations.
CXT has a Quick ratio of 0.89. This is amonst the worse of the industry: CXT underperforms 83.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.89
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CXT have decreased by -1.72% in the last year.
CXT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.61% yearly.
Looking at the last year, CXT shows a small growth in Revenue. The Revenue has grown by 6.86% in the last year.
CXT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.39% yearly.
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
Revenue 1Y (TTM)6.86%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%

3.2 Future

CXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.90% yearly.
CXT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y-2.78%
EPS Next 2Y6.83%
EPS Next 3Y8.9%
EPS Next 5YN/A
Revenue Next Year7.56%
Revenue Next 2Y7.6%
Revenue Next 3Y7.74%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.65 indicates a correct valuation of CXT.
Based on the Price/Earnings ratio, CXT is valued cheaper than 87.10% of the companies in the same industry.
CXT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.83.
Based on the Price/Forward Earnings ratio of 12.81, the valuation of CXT can be described as correct.
90.32% of the companies in the same industry are more expensive than CXT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, CXT is valued rather cheaply.
Industry RankSector Rank
PE 15.65
Fwd PE 12.81
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXT is valued cheaper than 82.26% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CXT is valued a bit cheaper than 77.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.33
EV/EBITDA 11.6
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.83%
EPS Next 3Y8.9%

6

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.11%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.12, CXT pays a better dividend. On top of this CXT pays more dividend than 86.29% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, CXT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CXT pays out 24.98% of its income as dividend. This is a sustainable payout ratio.
CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.98%
EPS Next 2Y6.83%
EPS Next 3Y8.9%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (11/7/2025, 8:04:00 PM)

After market: 62.45 0 (0%)

62.45

+1.1 (+1.79%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners110.42%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change0.51%
Market Cap3.59B
Revenue(TTM)1.49B
Net Income(TTM)151.30M
Analysts81.82
Price Target95.15 (52.36%)
Short Float %13.19%
Short Ratio14.86
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP24.98%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-28 2025-11-28 (0.17)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.68%
Min EPS beat(2)1.41%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)1.23%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)2.1%
EPS beat(12)9
Avg EPS beat(12)6.49%
EPS beat(16)13
Avg EPS beat(16)8.47%
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)2.69%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)3
Avg Revenue beat(8)0.18%
Revenue beat(12)5
Avg Revenue beat(12)0.47%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.49%
PT rev (3m)4.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.31%
EPS NY rev (1m)0.04%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 15.65
Fwd PE 12.81
P/S 2.33
P/FCF 24.33
P/OCF 18.73
P/B 3.05
P/tB N/A
EV/EBITDA 11.6
EPS(TTM)3.99
EY6.39%
EPS(NY)4.87
Fwd EY7.8%
FCF(TTM)2.57
FCFY4.11%
OCF(TTM)3.34
OCFY5.34%
SpS26.77
BVpS20.46
TBVpS-10.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number42.86
Profitability
Industry RankSector Rank
ROA 5.19%
ROE 12.88%
ROCE 11.9%
ROIC 8.52%
ROICexc 9.06%
ROICexgc 33.45%
OM 17.79%
PM (TTM) 9.84%
GM 42.98%
FCFM 9.59%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexgc growth 3Y39.7%
ROICexgc growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 7.66
Debt/EBITDA 3.05
Cap/Depr 45.56%
Cap/Sales 2.87%
Interest Coverage 5.41
Cash Conversion 51.71%
Profit Quality 97.42%
Current Ratio 1.2
Quick Ratio 0.89
Altman-Z 2.26
F-Score4
WACC9.15%
ROIC/WACC0.93
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
EPS Next Y-2.78%
EPS Next 2Y6.83%
EPS Next 3Y8.9%
EPS Next 5YN/A
Revenue 1Y (TTM)6.86%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%
Revenue Next Year7.56%
Revenue Next 2Y7.6%
Revenue Next 3Y7.74%
Revenue Next 5YN/A
EBIT growth 1Y-1.72%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year18.55%
EBIT Next 3Y14.58%
EBIT Next 5YN/A
FCF growth 1Y200.07%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y281.35%
OCF growth 3Y-8.23%
OCF growth 5YN/A

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


What is the valuation status for CXT stock?

ChartMill assigns a valuation rating of 6 / 10 to CRANE NXT CO (CXT). This can be considered as Fairly Valued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CXT stock?

The Price/Earnings (PE) ratio for CRANE NXT CO (CXT) is 15.65 and the Price/Book (PB) ratio is 3.05.


What is the expected EPS growth for CRANE NXT CO (CXT) stock?

The Earnings per Share (EPS) of CRANE NXT CO (CXT) is expected to decline by -2.78% in the next year.